Literature DB >> 28135357

Hypertension in 2017-What Is the Right Target?

Aram V Chobanian1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28135357     DOI: 10.1001/jama.2017.0105

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  10 in total

1.  The association between blood pressure and long-term outcomes of patients with ischaemic cardiomyopathy with and without surgical revascularization: an analysis of the STICH trial.

Authors:  Bert Andersson; Lilin She; Ru-San Tan; Panniyammakal Jeemon; Krzysztof Mokrzycki; Matthias Siepe; Alexander Romanov; Liliana E Favaloro; Ljubomir T Djokovic; P Krishnam Raju; Piotr Betlejewski; Normand Racine; Adam Ostrzycki; Weerachai Nawarawong; Siuli Das; Jean L Rouleau; George Sopko; Kerry L Lee; Eric J Velazquez; Julio A Panza
Journal:  Eur Heart J       Date:  2018-10-01       Impact factor: 29.983

2.  BP Targets in CKD, Mortality, and SPRINT: What Have We Learned?

Authors:  Stephen C Textor; Gary L Schwartz
Journal:  J Am Soc Nephrol       Date:  2017-07-20       Impact factor: 10.121

Review 3.  [Management of arterial hypertension].

Authors:  J A Wermelt; H Schunkert
Journal:  Herz       Date:  2017-08       Impact factor: 1.443

Review 4.  Evidence-based blood pressure reducing actions of electroacupuncture: mechanisms and clinical application.

Authors:  John C Longhurst; Stephanie C Tjen-A-Looi
Journal:  Sheng Li Xue Bao       Date:  2017-10-25

5.  Effects of Health Insurance Interruption on Loss of Hypertension Control in Women With and Women Without HIV.

Authors:  Andrew Edmonds; Christina Ludema; Joseph J Eron; Stephen R Cole; Adebola A Adedimeji; Mardge H Cohen; Hannah L Cooper; Margaret Fischl; Mallory O Johnson; Denise D Krause; Dan Merenstein; Joel Milam; Tracey E Wilson; Adaora A Adimora
Journal:  J Womens Health (Larchmt)       Date:  2017-07-06       Impact factor: 2.681

6.  Systolic Blood Pressure Response in SPRINT (Systolic Blood Pressure Intervention Trial) and ACCORD (Action to Control Cardiovascular Risk in Diabetes): A Possible Explanation for Discordant Trial Results.

Authors:  Chenxi Huang; Sanket S Dhruva; Andreas C Coppi; Frederick Warner; Shu-Xia Li; Haiqun Lin; Khurram Nasir; Harlan M Krumholz
Journal:  J Am Heart Assoc       Date:  2017-11-13       Impact factor: 5.501

7.  Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials.

Authors:  Sanjay Basu; Jeremy B Sussman; Joseph Rigdon; Lauren Steimle; Brian T Denton; Rodney A Hayward
Journal:  PLoS Med       Date:  2017-10-17       Impact factor: 11.069

8.  Dynamic treatment selection and modification for personalised blood pressure therapy using a Markov decision process model: a cost-effectiveness analysis.

Authors:  Sung Eun Choi; Margaret L Brandeau; Sanjay Basu
Journal:  BMJ Open       Date:  2017-11-15       Impact factor: 2.692

9.  Blood Pressure Targets: Will We Reach Definite Figures? I Currently Have Mine.

Authors:  Paulo César B Veiga Jardim
Journal:  Arq Bras Cardiol       Date:  2017-07       Impact factor: 2.000

10.  Association between systolic blood pressure and dementia in the Whitehall II cohort study: role of age, duration, and threshold used to define hypertension.

Authors:  Jessica G Abell; Mika Kivimäki; Aline Dugravot; Adam G Tabak; Aurore Fayosse; Martin Shipley; Séverine Sabia; Archana Singh-Manoux
Journal:  Eur Heart J       Date:  2018-09-01       Impact factor: 35.855

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.